Written by the Nuvirox Research Team
Key points
- Vitiligo happens when melanocytes (pigment-producing cells) are destroyed or lose function — the goal of any treatment is to encourage repigmentation.
- Published research on NAD+ precursors and pigmentation, however, shows nicotinamide riboside suppressing melanin production in the context of hyperpigmentation treatment.
- There is no research testing NAD+ precursors as a way to encourage repigmentation in vitiligo, and the closest available evidence points the opposite direction.
Short answer: no, and the honest reason why is more interesting than a simple "not studied." The research that does exist on NAD+ precursors and skin pigmentation is aimed at reducing melanin (for age spots and hyperpigmentation) — not increasing it, which is what vitiligo repigmentation actually requires.
What's actually happening in vitiligo, biologically?
Vitiligo results from the destruction or dysfunction of melanocytes, the cells that produce melanin pigment, through a combination of autoimmune attack and oxidative stress. Effective treatments (like phototherapy or, more recently, JAK inhibitors) work by calming that autoimmune activity and encouraging surviving melanocyte stem cells — often reservoired in hair follicles — to reactivate and repopulate the skin with pigment-producing cells.
What does the evidence actually show?
A 2024 study specifically investigated whether nicotinamide riboside (NR) could reduce hyperpigmentation caused by UVB light exposure in melanocyte cell models, precisely because NAD+ precursors had been observed to reduce melanogenesis in aged melanocytes. The study found NR suppressed melanin production and tyrosinase activity — useful for age spots and melasma, where the goal is less pigment, but the structural opposite of what vitiligo treatment is trying to achieve. Separately, general vitiligo research on melanocyte stem cell mobilization has not tested NAD+ precursors at all; it focuses on UV-based therapies and, more recently, JAK-STAT pathway inhibitors.
Study snapshot: Nicotinamide riboside and melanin production
| Model | Photo-irradiated (UVB) melanocyte cells |
| Intervention | Nicotinamide riboside (NR) |
| Finding | Suppressed melanogenesis and tyrosinase activity |
| Relevance to vitiligo | Opposite of the repigmentation goal vitiligo treatment requires |
The honest counterweight
We want to be direct here rather than soften this into vague "more research is needed" language: there is no research suggesting NAD+ precursor supplementation encourages the specific process — melanocyte reactivation and melanin synthesis — that vitiligo treatment needs. The one relevant strand of research runs the other way. This is a case where the honest answer to "does NAD+ help with X" is closer to "the evidence available points away from it," and we think that's more useful to know than a hedge.
When to see a doctor
Vitiligo is a diagnosis best made and managed by a dermatologist, partly because new repigmentation treatments (including topical JAK inhibitors, approved in the past few years) have meaningfully changed the treatment landscape, and partly because vitiligo can occasionally cluster with other autoimmune conditions worth screening for.
What's actually proven to help vitiligo
Narrowband UVB phototherapy has the longest track record for encouraging repigmentation. Topical corticosteroids and calcineurin inhibitors are standard for localized disease. Topical JAK inhibitors (like ruxolitinib cream) are a newer, FDA-approved option with solid trial data specifically for facial repigmentation. Camouflage makeup and, for widespread stable disease, depigmentation of remaining pigmented skin are options some patients pursue as well.
How does this relate to other NAD+ pigmentation research?
The pigmentation research on NAD+ precursors is actually more developed for the opposite cosmetic goal — reducing unwanted pigmentation like age spots and melasma — which is a separate topic from both vitiligo and from our coverage of NAD+ and gray hair, where the pigment-related question runs in yet another direction (hair pigment loss rather than skin depigmentation). If general skin health is your interest rather than a specific pigmentation goal, our page on NAD+ and eczema covers a condition where the inflammatory mechanism, at least, points in a more consistent direction.
For anyone specifically managing vitiligo who's also curious about general NAD+ precursor supplementation for unrelated wellness goals (energy, healthy aging), it's reasonable to pursue that separately — the point of this article is simply that vitiligo itself isn't a reason to expect a benefit, not that NAD+ precursors are harmful or inappropriate for other purposes. As always, review our page on NAD+ supplement side effects if you're considering starting any new supplement alongside your dermatology care.
To put a finer point on the mechanism: the hyperpigmentation study found NR suppressed both melanin production and tyrosinase activity (the key enzyme in melanin synthesis) in melanocytes exposed to UVB light — the exact opposite of what a vitiligo treatment would need to accomplish, since vitiligo treatment specifically aims to stimulate tyrosinase activity and melanocyte proliferation in affected areas. This isn't a subtle distinction; it's a directly opposing cellular effect.
If you're on a treatment plan involving phototherapy specifically, it's worth knowing that UV exposure itself increases oxidative stress and NAD+ turnover in skin cells broadly, which is an interesting area of overlap between vitiligo phototherapy mechanisms and general NAD+ biology — though again, this describes how existing proven vitiligo treatments work, not a reason to add an NAD+ supplement on top of them.
This is also a useful example of why "NAD+ supports healthy aging broadly" doesn't mean "NAD+ helps every age-related or skin-related condition" — cellular biology is specific, and a pathway that helps one process (like reducing unwanted pigmentation) can be neutral or even counterproductive for a related but distinct process (like restoring lost pigmentation), even though both involve the same underlying melanocyte cell type.
If you came to this article hoping for a supplement-based shortcut to repigmentation, we'd rather tell you plainly that the evidence doesn't support it than leave you with a vague, hedged answer that implies otherwise.
A board-certified dermatologist can also help you weigh the newer JAK-inhibitor options against your specific pattern, extent, and duration of depigmentation to find the most appropriate treatment plan for your situation specifically.
Ask specifically about combination approaches, since many patients do best with more than one treatment modality at once.
Frequently asked questions
Can NAD+ supplements help repigment vitiligo patches?
There's no supporting evidence, and the closest related research (on NR and melanin production) points the opposite direction.
Why would a NAD+ supplement company mention this if it doesn't help?
Because giving you an accurate answer, even a 'no,' is more useful than staying silent or implying a connection that isn't supported by the evidence.
What's the best-evidenced vitiligo treatment right now?
Narrowband UVB phototherapy and topical JAK inhibitors both have solid clinical trial support for repigmentation; a dermatologist can help match the right option to your specific presentation.
From Nuvirox
Why we formulated NAD+ Restore
To be direct: NAD+ Restore is a general wellness supplement, not a treatment for this condition, and it shouldn't be used as a substitute for medical care. If you're separately interested in cellular energy support once your care team is in the loop, here's what's in it.
- 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials
- 150 mg trans-resveratrol (Japanese Knotweed) + 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support
- 10 mg galactomannans from fenugreek — to support absorption
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should
The bottom line: this is one of the more clear-cut "not for this" answers in NAD+ research. The available evidence on NAD+ precursors and pigmentation runs counter to what vitiligo repigmentation needs, and dermatology-guided treatment remains the evidence-backed path forward.
References
- Nicotinamide Riboside Ameliorates Hyperpigmentation on Photo-Irradiated Skin. Cosmetics. 2024. doi:10.3390/cosmetics11030073.
- Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. PMCID: PMC5466503.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.